Tympano-ossicular allografts and HIV transmission

American Journal of Otology

Volumn 19, Issue 6, 1998, Pages 704-708

  Janssens De Varebeke, S ^a   Goubau, P ^b   Beuselinck, H K ^b   Somers, Th ^a   Offeciers, F E ^a   Govaerts, P J ^a  

^a SINT AUGUSTINUS HOSPITAL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

HIV transmission; Homograft; Middle ear surgery; PCR; Reconstruction; Tympano ossicular allograft

Indexed keywords

FORMALDEHYDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALLOGRAFT; ARTICLE; AUDITORY OSSICLE; CLINICAL ARTICLE; GENE AMPLIFICATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MIDDLE EAR SURGERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SKIN BIOPSY; VIRUS TRANSMISSION;

DISINFECTANTS; DNA, VIRAL; EAR OSSICLES; FORMALDEHYDE; HIV INFECTIONS; HIV-1; HUMANS; INFECTION CONTROL; ORGAN PRESERVATION; PROSPECTIVE STUDIES; SINGLE-BLIND METHOD; TRANSPLANTATION, HOMOLOGOUS; TYMPANIC MEMBRANE;

EID: 0031734923     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Marquet J. Twelve years of experience with homograft tympanoplasty. Otolaryngol Clin North Am 1977;10:581.
2. Schilder AGM, Govaerts PJ, Somers Th, et al. Tympano-ossicular allografts in childhood cholesteatoma. Int J Ped Otolaryngol 1997; 42:31-40.
3. Claes J, Van de Heyning PH, Creten W, et al. Functional and anatomical results of allograft tympanoplasty. Otolaryngol Head Neck Surg 1990:351-4.
4. Janssens de Varebeke S, Govaerts PJ, Somers Th, et al. The "two-hole" ossiculoplasty technique. Laryngoscope 1996;106:507-10.
5. Hamans EPPM, Govaerts PJ, Somers Th, et al. Allograft tympanoplasty type 1 in the childhood population. Ann Otol Rhinol Laryngol 1996;105:871-6.
6. Levy JA. The retroviruses and pathogenesis of HIV infection. In: Lawrence Corey, ed. AIDS, problems and prospects. New York: Norton Medical Books, 1993:3-15.
7. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
8. Brugere-Picoux J, Rerat A. Bovine spongiform encephalopathy. Review of data collected since the statement of February 6, 1996. Bull Acad Natl Med 1996;180:1007-12.
9. Glasscock ME, Jackson CG, Knox GW. Can acquired immunodeficiency syndrome and Creutzfeldt-Jakob disease be transmitted via otologic homografts? Arch Otolaryngol Head Neck Surg 1988;114:1252-5.
10. Davis AE. Homograft materials in otolaryngology: the risk of transmitting HIV. Clin Otolaryngol 1988;13:159-61.
11. Tange RA, Troost D, Limburg M. Progressive fatal dementia (Creutzfeldt-Jakob disease) in a patient who received homograft tissue for tympanic membrane closure. Eur Arch Otorhinolaryngol 1990;247:199-201.
12. Asselmeier MA, Caspari RB, Bottenfield S. A review of allograft processing and sterilization techniques and their role in transmission of the human immunodeficiency virus. Am J Sport Med 1993;21:170-5.
13. Meylan PRA, Duscher A, Mudry A, et al. Risk of transmission of human immunodeficiency virus infection during tympano-ossicular homograft: an experimental study. Laryngoscope 1996;106: 334-7.
14. Bujia J, Wilmes E, Kastenbauer E, et al. Influence of chemical allograft preservation procedures on the human immunodeficiency virus. Laryngoscope 1996;106:645-7.
15. Majoor M, Meeuwsen F, Huizing E, et al. Donorselektie en preservatiemethode ter voorkoming van overdracht van AIDS en ziekte van Creutzfeldt-Jakob met allogene transplantaten in de oorchirurgie. Ned Tijdschr Geneeskd 1993;137:1708-11.
16. Mellonig JT, Prewett AB, Moyer MP. HIV inactivation in a bone allograft. J Periodontol 1992;63:979-83.
17. Buck BE, Resnick L, Shah SM, et al. HIV cultured from bone: implications for transplantation. Clin Orthop 1990;251:249-53.
18. Straudte HW, Breickmann B. Die thermische aufbereitung von homologen knochentransplantaten für die Knochenbank als zusätzliche sicherheit zur AIDS-prophylaxe. Z Orthop 1991;129: 108-10.
19. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989;339:237-8.
20. Vandamme AM, Fransen K, Debaisieux L, et al. Standardisation of primers and an algorithm for HIV-1 diagnostic PCR evaluated in patients harbouring strains of diverse geographical origin. J Virol Methods 1994;51:305-16.
21. Vandamme AM. Polymerase chain reaction (PCR) as a diagnostic tool in HIV infection. Verh K Acad Geneeskd Belg 1994;LVI No. 3:231-65.
22. Levy JA. Retroviridae. In: Lonnette EH, Halonen P, Murphy FA, eds. Laboratory diagnosis of infectious diseases; principles and practice. New York: Springer-Verlag, 1988;II,677-91.
23. Simonds RJ. HIV transmission by organ and tissue transplantation. AIDS 1993;7(Suppl 2):s35-8.
24. Cook SD, Salkeld SL, Prewett AB. Simian immunodeficiency virus (human HIV-II) transmission in allograft bone procedures. Spine 1995:20:1338-42.
25. Guidelines for preventing transmission of Human Immunodeficiency Virus through transplantation of human tissue and organs. MMWR 1994;43:1-17.
26. Marquet J. Allograft tympanoplasty today. In: Babighian G, Veldman JE, eds. Transplants and implants in otology. Amsterdam: Kugler and Ghedini, 1988:17-25.
27. Buck BE, Malinin TI. Human bone and tissue allografts. Preparation and safety. Clin Orthop 1994;303:8-17.
28. Spire B, Barre Sinoussi F, Montagnier L. Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet 1984;2:899-901.
29. Knaepler H, Koch F, Bugany H. Untersuchungen zur HIV-Inaktivierung in allogenen Knochentransplantaten durch chemische Desinfektion und radioaktive Bestrahlung. Unfallchirurg 1992;18:1-6.
30. Dickson WA, Inglis TJJ. Cialit preserved cartilage: failure to guarantee sterility. Br J Plast Surg 1988;41:408-9.
31. Röder W, Müller W, Merz H. Ist Cialit zur HIV-abtötung geeignet? Dtsch Ärztebl 1991;88:2416.
32. Perkins R. Human homograft otologic tissue transplantation buffered formaldehyde preparation. Trans Am Acad Ophtalmol Otolaryngol 1970;74:278-82.
33. Leguillette JL, Buffet-Janvresse C. Sida et allogreffes en otologie. Lettre ORL Chir Cerv-Fac 1994;168:3-4.